Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 722-733.e11
Open Access | Times Cited: 480

Showing 1-25 of 480 citing articles:

Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang, Rong Zhao, Lijuan Gao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 825
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
H. J. Yang, Wei Wang, Zimin Chen, et al.
Nature (2020) Vol. 586, Iss. 7830, pp. 572-577
Open Access | Times Cited: 755
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 711
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong, Tong Dai, Yujun Wei, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 538
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Omna Sharma, Ali A. Sultan, Hong Ding, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 515
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1367-1382.e17
Open Access | Times Cited: 497
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li, Wei-Yu Chi, Jun-Han Su, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 428
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 8, pp. 1107-1119
Open Access | Times Cited: 419
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan, Qianqian Zheng, Hongxia Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 403
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu, Zongyi Yi, Yong Shen, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1728-1744.e16
Open Access | Times Cited: 374
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung, Melissa N. Thone, Young Jik Kwon
Advanced Drug Delivery Reviews (2020) Vol. 170, pp. 1-25
Open Access | Times Cited: 347
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 316
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma, Fan Zou, Fei Yu, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1315-1330.e9
Open Access | Times Cited: 279
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li, Bin Huang, Min Wu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 240
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Ioannis P. Trougakos, Κimon Stamatelopoulos, Evangelos Terpos, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 240
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Jeroen Pollet, Wen‐Hsiang Chen, Ulrich Strych
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 71-82
Open Access | Times Cited: 227
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2097-2111
Open Access | Times Cited: 222
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
Yin-Feng Kang, Cong Sun, Zhen Zhuang, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 2738-2752
Open Access | Times Cited: 191
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 190
Adjuvants for Coronavirus Vaccines
Zhihui Liang, Haoru Zhu, Xin Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 181
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177
Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su, Lanying Du, Shibo Jiang
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 211-219
Open Access | Times Cited: 164
Page 1 - Next Page

Scroll to top